{"database": "lobbying", "table": "lobbying_activities", "rows": [[2512317, "f352ebbe-5443-428f-930f-2a5ae4bbe1f8", "Q3", "THE CONAFAY GROUP, LLC", 401004840, "EMERGEX VACCINES HOLDING LTD.", 2020, "third_quarter", "MED", "Influenza and respiratory disease research", "SENATE", null, null, 0, 0, "2020-10-16T18:02:52.363000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2512317"], "units": {}, "query_ms": 3.859240096062422, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}